您好,欢迎访问中国水产科学研究院 机构知识库!

Sustainable use of CRISPR/Cas in fish aquaculture: the biosafety perspective

文献类型: 外文期刊

作者: Okoli, Arinze S. 1 ; Blix, Torill 1 ; Myhr, Anne I. 1 ; Xu, Wenteng 3 ; Xu, Xiaodong 4 ;

作者机构: 1.SIVA Innovat Ctr, GenOk Ctr Biosafety, Tromso, Norway

2.Arctic Univ Norway UiT, Norwegian Coll Fishery Sci, Tromso, Norway

3.Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao 266071, Peoples R China

4.Qingdao Vland Biotech Co Grp, Qingdao 266061, Peoples R China

关键词: CRISPR/Cas; Aquaculture; Salmon; Risk assessment; Sustainability; Genome-editing; Gene modification; Genetically modified organism; GMO

期刊名称:TRANSGENIC RESEARCH ( 影响因子:2.788; 五年影响因子:2.377 )

ISSN: 0962-8819

年卷期:

页码:

收录情况: SCI

摘要: Aquaculture is becoming the primary source of seafood for human diets, and farmed fish aquaculture is one of its fastest growing sectors. The industry currently faces several challenges including infectious and parasitic diseases, reduced viability, fertility reduction, slow growth, escapee fish and environmental pollution. The commercialization of the growth-enhanced AquAdvantage salmon and the CRISPR/Cas9-developed tilapia (Oreochromis niloticus) proffers genetic engineering and genome editing tools, e.g. CRISPR/Cas, as potential solutions to these challenges. Future traits being developed in different fish species include disease resistance, sterility, and enhanced growth. Despite these notable advances, off-target effect and non-clarification of trait-related genes among other technical challenges hinder full realization of CRISPR/Cas potentials in fish breeding. In addition, current regulatory and risk assessment frameworks are not fit-for purpose regarding the challenges of CRISPR/Cas notwithstanding that public and regulatory acceptance are key to commercialization of products of the new technology. In this study, we discuss how CRISPR/Cas can be used to overcome some of these limitations focusing on diseases and environmental release in farmed fish aquaculture. We further present technical limitations, regulatory and risk assessment challenges of the use of CRISPR/Cas, and proffer research strategies that will provide much-needed data for regulatory decisions, risk assessments, increased public awareness and sustainable applications of CRISPR/Cas in fish aquaculture with emphasis on Atlantic salmon (Salmo salar) breeding.

  • 相关文献
作者其他论文 更多>>